The miR-200 Family Controls -Tubulin III Expression and Is Associated With Paclitaxel-Based Treatment Response and Progression-Free Survival in Ovarian Cancer Patients
Endocrine-Related Cancer - United Kingdom
doi 10.1677/erc-10-0148
Full Text
Open PDFAbstract
Available in full text
Date
November 4, 2010
Authors
Publisher
Bioscientifica